ADOPTIVE CELLULAR IMMUNOTHERAPY
\ɐdˈɒptɪv sˈɛljʊləɹ ɪmjˈuːnə͡ʊθˌɛɹəpi], \ɐdˈɒptɪv sˈɛljʊləɹ ɪmjˈuːnəʊθˌɛɹəpi], \ɐ_d_ˈɒ_p_t_ɪ_v s_ˈɛ_l_j_ʊ_l_ə_ɹ ɪ_m_j_ˈuː_n_əʊ_θ_ˌɛ_ɹ_ə_p_i]\
Sort: Oldest first
-
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
By DataStellar Co., Ltd
